Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies

Table 4 Results of hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma[58]

Ref.	Patients	Country	Median follow-up (mo)	Median OS (mo)	Median DFS (mo)	Morbidity	Mortality
Baratti et al	12	Italy	27	-	24	-	0%
Baratti et al	12	Italy	64	-	11	8.3%	0%
Blackham et al	34	United States	72	40.8	9.1	-	-
Brigand et al	15	France	46.7	35.6	-	-	0%
Chua et al	20	Australia	18.1	29.5	7.2	65.0%	5%
Sebbag et al	33	United States	21.3	31	-	33.0%	3%
Tudor et al	20	Australia	18	30	8	65.0%	5%
Deraco et al	61	Italy	20	-	28	23.0%	0%
Deraco et al	116	Italy	-	31.4	14.4	41.3%	2.6%
Loggie et al	12	United States	45.2	34.2	-	33.0%	8%
Ma et al	12	Turkey	10	-	-	90.0%	20%
Macuks et al	12	Turkey	-	-	-	-	-
Markman et al	19	United States	25	19	-	-	-
Feldman et al	49	United States	-	92	17	25.0%	-
Chua et al	26	Australia, Italy, France, United States, United Kingdom, Germany	54	-	-	26.9%	0%
Schaub et al	104	United States	49.4	52	20.8	-	-
Yan et al	401	Australia, Italy, France, United States, United Kingdom, Germany	33	53	-	46.0%	2%
Yano et al	17	United Kingdom	13	-	-	41.0%	12%
Yonemura et al	21	Japan	-	-	-	46.2%	-
Elias et al	26	France	54	> 100	40	54.0%	4%

OS: Overall survival; DFS: Disease-free survival.